Primary Cells Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Origin ; By Type ; By End User ; By Region

Description

Global Primary Cells Market Size Doubles to Reach USD 8.6 Billion by 2029.

Global primary cells market is flourishing because of increasing adoption of technology advancements and growing cancer research and development.

BlueWeave Consulting, a leading strategic consulting and Market research firm, in its recent study, estimated global primary cells market size at USD 4.29 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global primary cells market size to grow at a significant CAGR of 11.6% reaching a value of USD 8.6 billion by 2029. Major growth factors of global primary cells market include an increasing incidence of cancer, growing government support for cancer research, and expanding infrastructure to support the healthcare industry. The growing prevalence of chronic diseases worldwide, such as cancer, infections, autoimmune disorders, diabetes, and cardiovascular diseases, is a significant contributor to the growth of the primary cell market. It has also led to a rise in research activities for advanced therapies. The use of primary cell cultures for drug screening and in-vitro testing is also becoming increasingly popular, contributing to the growth of the primary cell market. The global primary cells market is being driven by advancements in genetic engineering and increased funding for research into cellular treatments. However, concerns regarding primary cell culture contamination are anticipated to restrain the overall market growth during the period in analysis.

Global Primary Cells Market - Overview:

The primary cells market refers to the market for primary cells, which are cells that have been freshly isolated from living tissues or organs, typically from humans or animals. These cells are used for research purposes, including drug discovery and development, toxicology testing, and basic research. Primary cells are important tools for studying biological processes and diseases, and they are widely used in both academic and commercial research settings. The primary cells market includes the production, distribution, and sale of primary cells, as well as related products and services such as cell culture media, reagents, and cell isolation kits.

Impact of COVID-19 on Global Primary Cells Market

COVID-19 had a positive impact on primary cell market. Primary cell culture is being used by researchers to better understand the infection and build standardized epithelial cell culture models. These models can assist duplicate the features of the respiratory tract, perhaps leading to breakthrough scientific findings with medical applications. In addition, the identification of primary cells for the treatment of many diseases is expanding. Due to their increased use in a variety of healthcare applications, private associations, biotech businesses, and government agencies have increased their interest and investment in this area. The growing utilization of primary cell cultures for viral synthesis, which is then used to make numerous vaccines, is also projected to move the market ahead.

Global Primary Cells Market - By Region:

Global primary cells market covers five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America held the highest share of revenue in the primary cell culture market and this trend is expected to continue throughout the forecast period. The growth in the region's market can be attributed to factors such as the high cost of healthcare, the increasing elderly population, the rising prevalence of chronic illnesses, and government funding support. Furthermore, the market in the region is expanding due to the focus of market players on developing innovative cell culture applications, improved instrumentation, a wide range of cell types, and the study of their cellular interactions.

Competitive Landscape

Major players operating in global primary cells market include Thermo Fisher Scientific Inc, Merck Group, Lonza, Cell Biologics, Inc., PromoCell - Human Centered Science, ZenBio, Inc., STEMCELL Technologies Inc, and AllCells. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Primary Cells Market. It also highlights the factors driving forecasts of total Market size. The report promises to provide recent technology trends in Global Primary Cells Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the Market.

Product Code: BWC23223

1. Research Framework

1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation

2. Executive Summary

3. Global Primary Cells Market Insights

3.1. Industry Value Chain Analysis
3.2. DROC Analysis
- 3.2.1. Growth Drivers
  - 3.2.1.1. Increasing Cancer Research
  - 3.2.1.2. Advancement in Technologies
- 3.2.2. Restraints
  - 3.2.2.1. Concern Regarding Primary Cell Culture Contamination
- 3.2.3. Opportunities
  - 3.2.3.1. Advancing Biomedical Research Using Primary Cells in 3D Cultures
- 3.2.4. Challenges
  - 3.2.4.1. Impact on Supply Chain Due to Covid
3.3. Technology Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat of New Entrants
- 3.5.4. Threat of Substitutes
- 3.5.5. Intensity of Rivalry

4. Global Primary Cells Market Overview

4.1. Market Size & Forecast, 2019-2029
- 4.1.1. By Value (USD Million)
4.2. Market Share & Forecast
- 4.2.1. By Origin
  - 4.2.1.1. Human Primary Cells
  - 4.2.1.2. Animal Primary Cells
- 4.2.2. By Type
  - 4.2.2.1. Hematopoietic Cells
  - 4.2.2.2. Dermatocytes
  - 4.2.2.3. Gastrointestinal Cells
  - 4.2.2.4. Hepatocytes
  - 4.2.2.4.1. Cryopreserved Hepatocytes
  - 4.2.2.4.2. Fresh Hepatocytes
  - 4.2.2.5. Others (Lung Cells, Renal Cells, Heat Cells, Musculoskeletal Cells, Primary Cells)
- 4.2.3. By End User
  - 4.2.3.1. Life Science Research Companies
  - 4.2.3.2. Research Institutes
- 4.2.4. By Region
  - 4.2.4.1. North America
  - 4.2.4.2. Europe
  - 4.2.4.3. Asia Pacific (APAC)
  - 4.2.4.4. Latin America (LATAM)
  - 4.2.4.5. Middle East and Africa (MEA)

5. North America Primary Cells Market

5.1. Market Size & Forecast, 2019-2029
- 5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
- 5.2.1. By Origin
- 5.2.2. By Type
- 5.2.3. By End User
- 5.2.4. By Country
  - 5.2.4.1. United States
  - 5.2.4.1.1. By Origin
  - 5.2.4.1.2. By Type
  - 5.2.4.1.3. By End User
  - 5.2.4.2. Canada
  - 5.2.4.2.1. By Origin
  - 5.2.4.2.2. By Type
  - 5.2.4.2.3. By End User

6. Europe Primary Cells Market

6.1. Market Size & Forecast, 2019-2029
- 6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
- 6.2.1. By Origin
- 6.2.2. By Type
- 6.2.3. By End User
- 6.2.4. By Country
  - 6.2.4.1. Germany
  - 6.2.4.1.1. By Origin
  - 6.2.4.1.2. By Type
  - 6.2.4.1.3. By End User
  - 6.2.4.2. United Kingdom
  - 6.2.4.2.1. By Origin
  - 6.2.4.2.2. By Type
  - 6.2.4.2.3. By End User
  - 6.2.4.3. Italy
  - 6.2.4.3.1. By Origin
  - 6.2.4.3.2. By Type
  - 6.2.4.3.3. By End User
  - 6.2.4.4. France
  - 6.2.4.4.1. By Origin
  - 6.2.4.4.2. By Type
  - 6.2.4.4.3. By End User
  - 6.2.4.5. Spain
  - 6.2.4.5.1. By Origin
  - 6.2.4.5.2. By Type
  - 6.2.4.5.3. By End User
  - 6.2.4.6. Belgium
  - 6.2.4.6.1. By Origin
  - 6.2.4.6.2. By Type
  - 6.2.4.6.3. By End User
  - 6.2.4.7. Russia
  - 6.2.4.7.1. By Origin
  - 6.2.4.7.2. By Type
  - 6.2.4.7.3. By End User
  - 6.2.4.8. The Netherlands
  - 6.2.4.8.1. By Origin
  - 6.2.4.8.2. By Type
  - 6.2.4.8.3. By End User
  - 6.2.4.9. Rest of Europe
  - 6.2.4.9.1. By Origin
  - 6.2.4.9.2. By Type
  - 6.2.4.9.3. By End User

7. Asia-Pacific Primary Cells Market

7.1. Market Size & Forecast, 2019-2029
- 7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
- 7.2.1. By Origin
- 7.2.2. By Type
- 7.2.3. By End User
- 7.2.4. By Country
  - 7.2.4.1. China
  - 7.2.4.1.1. By Origin
  - 7.2.4.1.2. By Type
  - 7.2.4.1.3. By End User
  - 7.2.4.2. India
  - 7.2.4.2.1. By Origin
  - 7.2.4.2.2. By Type
  - 7.2.4.2.3. By End User
  - 7.2.4.3. Japan
  - 7.2.4.3.1. By Origin
  - 7.2.4.3.2. By Type
  - 7.2.4.3.3. By End User
  - 7.2.4.4. South Korea
  - 7.2.4.4.1. By Origin
  - 7.2.4.4.2. By Type
  - 7.2.4.4.3. By End User
  - 7.2.4.5. Australia & New Zealand
  - 7.2.4.5.1. By Origin
  - 7.2.4.5.2. By Type
  - 7.2.4.5.3. By End User
  - 7.2.4.6. Indonesia
  - 7.2.4.6.1. By Origin
  - 7.2.4.6.2. By Type
  - 7.2.4.6.3. By End User
  - 7.2.4.7. Malaysia
  - 7.2.4.7.1. By Origin
  - 7.2.4.7.2. By Type
  - 7.2.4.7.3. By End User
  - 7.2.4.8. Singapore
  - 7.2.4.8.1. By Origin
  - 7.2.4.8.2. By Type
  - 7.2.4.8.3. By End User
  - 7.2.4.9. Vietnam
  - 7.2.4.9.1. By Origin
  - 7.2.4.9.2. By Type
  - 7.2.4.9.3. By End User
  - 7.2.4.10. Rest of APAC
  - 7.2.4.10.1. By Origin
  - 7.2.4.10.2. By Type
  - 7.2.4.10.3. By End User

8. Latin America Primary Cells Market

8.1. Market Size & Forecast, 2019-2029
- 8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
- 8.2.1. By Origin
- 8.2.2. By Type
- 8.2.3. By End User
- 8.2.4. By Country
  - 8.2.4.1. Brazil
  - 8.2.4.1.1. By Origin
  - 8.2.4.1.2. By Type
  - 8.2.4.1.3. By End User
  - 8.2.4.2. Mexico
  - 8.2.4.2.1. By Origin
  - 8.2.4.2.2. By Type
  - 8.2.4.2.3. By End User
  - 8.2.4.3. Argentina
  - 8.2.4.3.1. By Origin
  - 8.2.4.3.2. By Type
  - 8.2.4.3.3. By End User
  - 8.2.4.4. Peru
  - 8.2.4.4.1. By Origin
  - 8.2.4.4.2. By Type
  - 8.2.4.4.3. By End User
  - 8.2.4.5. Rest of LATAM
  - 8.2.4.5.1. By Origin
  - 8.2.4.5.2. By Type
  - 8.2.4.5.3. By End User

9. Middle East & Africa Primary Cells Market

9.1. Market Size & Forecast, 2019-2029
- 9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
- 9.2.1. By Origin
- 9.2.2. By Type
- 9.2.3. By End User
- 9.2.4. By Country
  - 9.2.4.1. Saudi Arabia
  - 9.2.4.1.1. By Origin
  - 9.2.4.1.2. By Type
  - 9.2.4.1.3. By End User
  - 9.2.4.2. UAE
  - 9.2.4.2.1. By Origin
  - 9.2.4.2.2. By Type
  - 9.2.4.2.3. By End User
  - 9.2.4.3. Qatar
  - 9.2.4.3.1. By Origin
  - 9.2.4.3.2. By Type
  - 9.2.4.3.3. By End User
  - 9.2.4.4. Kuwait
  - 9.2.4.4.1. By Origin
  - 9.2.4.4.2. By Type
  - 9.2.4.4.3. By End User
  - 9.2.4.5. South Africa
  - 9.2.4.5.1. By Origin
  - 9.2.4.5.2. By Type
  - 9.2.4.5.3. By End User
  - 9.2.4.6. Nigeria
  - 9.2.4.6.1. By Origin
  - 9.2.4.6.2. By Type
  - 9.2.4.6.3. By End User
  - 9.2.4.7. Algeria
  - 9.2.4.7.1. By Origin
  - 9.2.4.7.2. By Type
  - 9.2.4.7.3. By End User
  - 9.2.4.8. Rest of MEA
  - 9.2.4.8.1. By Origin
  - 9.2.4.8.2. By Type
  - 9.2.4.8.3. By End User

10. Competitive Landscape

10.1. List of Key Players and Their Offerings
10.2. Global Primary Cells Company Market Share Analysis, 2022
10.3. Competitive Benchmarking, By Operating Parameters
10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Primary Cells Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

12.1. Thermo Fisher Scientific Inc
12.2. Merck Group
12.3. Lonza
12.4. Cell Biologics, Inc.
12.5. PromoCell - Human Centered Science
12.6. ZenBio, Inc.
12.7. STEMCELL Technologies Inc
12.8. AllCells
12.9. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

14.1. Qualitative Research
- 14.1.1. Primary & Secondary Research
14.2. Quantitative Research
14.3. Market Breakdown & Data Triangulation
- 14.3.1. Secondary Research
- 14.3.2. Primary Research
14.4. Breakdown of Primary Research Respondents, By Region
14.5. Assumptions & Limitations